Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data

@inproceedings{Volz2021TransmissionOS,
  title={Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data},
  author={Erik M. Volz and Swapnil Mishra and Meera Chand and Jeffrey C. Barrett and Robert Johnson and Lily Geidelberg and Wes Hinsley and Daniel J. Laydon and Gavin Dabrera and {\'A}ine Niamh O'toole and Roberto Amato and Manon Ragonnet-Cronin and Ian Harrison and Ben Jackson and Cristina V. Ariani and Olivia Boyd and Nicholas James Loman and John T. McCrone and Sonia Gonçalves and David Jorgensen and Richard Myers and Verity Hill and David K. Jackson and Katy A. M. Gaythorpe and Natalie Groves and John Sillitoe and Dominic P. Kwiatkowski and Seth Flaxman and Oliver Ratmann and Samir Bhatt and Susan Hopkins and Axel Gandy and Andrew Rambaut and Neil M. Ferguson},
  booktitle={medRxiv},
  year={2021}
}
The SARS-CoV-2 lineage B.1.1.7, now designated Variant of Concern 202012/01 (VOC) by Public Health England, originated in the UK in late Summer to early Autumn 2020. We examine epidemiological evidence for this VOC having a transmission advantage from several perspectives. First, whole genome sequence data collected from community-based diagnostic testing provides an indication of changing prevalence of different genetic variants through time. Phylodynamic modelling additionally indicates that… 
Genomic epidemiology identifies emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States
TLDR
The prevalence and growth dynamics of this variant of SARS-CoV-2 in the United States is investigated, tracking it back to its early emergence and onward local transmission, and it is found that the RT-qPCR testing anomaly of S gene target failure (SGTF), first observed in the U.K., was a reliable proxy for B.1.1 .1.7 detection.
SARS-CoV-2 lineage dynamics in England from January to March 2021 inferred from representative community samples
TLDR
Describing lineage dynamics and phylogenetic relationships using sequences obtained from a random community sample who provided a throat and nose swab for rt-PCR during the first three months of 2021 as part of the REal-time Assessment of Community Transmission-1 (REACT-1) study suggests sequence data from representative community surveys such as REact-1 can augment routine genomic surveillance.
Increased transmission of SARS-CoV-2 lineage B.1.1.7 (VOC 2020212/01) is not accounted for by a replicative advantage in primary airway cells or antibody escape
TLDR
It is demonstrated that there is no difference in viral replication between B.1.1 .1.7 and other contemporaneous SARS-CoV-2 strains in primary human airway epithelial (HAE) cells.
Genomic sequencing of SARS-CoV-2 in Rwanda reveals the importance of incoming travelers on lineage diversity
TLDR
A shift in variant distribution towards the emerging sub-lineage A.23.1.1 that is currently dominating is reported, and an important role of neighboring countries in seeding introductions into Rwanda is uncovered, including those from which no genomic sequences were available.
Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2 with grinch
TLDR
Using a combination of data from routine surveillance, genomic sequencing and international travel, a custom tracking website is built which hosts this daily report and will continue to include novel SARS-CoV-2 lineages of concern as they are detected.
Early introductions and community transmission of SARS-CoV-2 variant B.1.1.7 in the United States
TLDR
Using travel, genomic, and diagnostic testing data, it is highlighted the primary ports of entry for B.1.1 .1.7 in the US and locations of possible underreported cases, and evidence for increased community transmission in several states is provided.
Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2.
TLDR
Using a combination of data from routine surveillance, genomic sequencing and international travel, a custom tracking website is built which hosts this daily report and will continue to include novel SARS-CoV-2 lineages of concern as they are detected.
A phylogeny-based metric for estimating changes in transmissibility from recurrent mutations in SARS-CoV-2
TLDR
A tendency for estimated transmissibility within clades to slightly decrease over time in most clades is observed, which is consistent with the expectation of a decay in transmissability in mainly non-recombining lineages caused by the accumulation of weakly deleterious mutations.
Emergence of first strains of Sars-CoV-2 lineage B.1.1.7 in Romania
United Kingdom reported the emergence of a new and highly transmissible SARS-CoV-2 variant B.1.1.7. that rapidly spread to other contries. The impact of this new mutation that occurs in the S
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 57 REFERENCES
Establishment & lineage dynamics of the SARS-CoV-2 epidemic in the UK
TLDR
The fine-scale genetic lineage structure of this epidemic is revealed through analysis of 50,887 SARS-CoV-2 genomes, including 26,181 from the UK sampled throughout the country's first wave of infection.
Evaluating the effects of SARS-CoV-2 Spike mutation D614G on transmissibility and pathogenicity
TLDR
Investigation of the hypothesis for positive selection of Spike 614G at the level of an individual country, the United Kingdom, using more than 25,000 whole genome SARS-CoV-2 sequences collected by COVID-19 Genomics UK Consortium finds that Spike 6 14G clusters are introduced in the UK later on average than 614D clusters and grow to larger size after adjusting for time of introduction.
A dynamic nomenclature proposal for SARS-CoV-2 to assist genomic epidemiology
TLDR
This work presents a rational and dynamic virus nomenclature that uses a phylogenetic framework to identify those lineages that contribute most to active spread and will assist in tracking and understanding the patterns and determinants of the global spread of SARS-CoV-2.
The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity
TLDR
It is observed that the N439K mutation resulted in immune escape from a panel of neutralizing monoclonal antibodies, including one in clinical trials, as well as from polyclonal sera from a sizeable fraction of persons recovered from infection.
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
TLDR
The results show that major non-pharmaceutical interventions and lockdown in particular have had a large effect on reducing transmission and continued intervention should be considered to keep transmission of SARS-CoV-2 under control.
Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020
TLDR
It is currently unclear whether this variant of SARS-CoV-2 is spreading because of a transmission advantage of the virus or whether high incidence in Spain followed by dissemination through tourists is sufficient to explain the rapid rise in multiple countries.
Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70
TLDR
Recurrent emergence and significant onward transmission of a six-nucleotide out of frame deletion in the S gene, which results in loss of two amino acids: H69 and V70 is reported, which likely acts as a permissive mutation that allows acquisition of otherwise deleterious immune escape mutations.
Semi-Mechanistic Bayesian Modeling of COVID-19 with Renewal Processes.
TLDR
A general Bayesian approach to modeling epidemics such as COVID-19, which provides a fully generative model for latent infections and observations deriving from them, including deaths, cases, hospitalizations, ICU admissions and seroprevalence surveys.
Improving Bayesian population dynamics inference: a coalescent-based model for multiple loci.
TLDR
This work presents a generalization of the GMRF model that allows for the analysis of multilocus sequence data and recovers an older and more reconcilable TMRCA for a classic ancient DNA data set.
...
1
2
3
4
5
...